Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
3-MMC (1) ·
Asenapine (1) ·
Butylone (1) ·
Cathinone (1) ·
Chlorpromazine (1) ·
Cholecalciferol (vitamin D3) (1) ·
Droperidol (1) ·
Ephylone (1) ·
Ergocalciferol (vitamin D2) (1) ·
Ethcathinone (1) ·
Ethylone (1) ·
Fluphenazine (1) ·
Hexedrone (1) ·
Iloperidone (1) ·
Loxapine (1) ·
Lurasidone (1) ·
Mephedrone (1) ·
Methcathinone (1) ·
Methylone (1) ·
Mexedrone (1) ·
Molindone (1) ·
N-Ethylhexedrone (1) ·
N-Ethylpentedrone (1) ·
Paliperidone (1) ·
Pentedrone (1) ·
Perphenazine (1) ·
Pimozide (1) ·
Thioridazine (1) ·
Thiothixene (1) ·
Trifluoperazine (1) ·
Ziprasidone (1)
None (14) ·
Drisdol, Calcidol; also many OTC preparations (1) ·
Fanapt (1) ·
Geodon (1) ·
Inapsine (1) ·
Invega (1) ·
Latuda (1) ·
Loxitane (1) ·
Many OTC; Rx 50,000 IU also available (1) ·
Mellaril (1) ·
Moban (1) ·
Navane (1) ·
Orap (1) ·
Prolixin (1) ·
Saphris (1) ·
Stelazine (1) ·
Thorazine (1) ·
Trilafon (1)
Butyrophenone D2 antagonist (1) ·
Cathinone analogue; monoamine reuptake inhibitor (2) ·
D2 receptor antagonist; also H1, alpha-1, muscarinic antagonist (1) ·
D2/5-HT2A antagonist (1) ·
D2/5-HT2A antagonist; 5-HT7 antagonist (1) ·
D2/5-HT2A antagonist; active metabolite of risperidone (1) ·
D2/5-HT2A antagonist; SRI and NRI (1) ·
Dibenzoxazepine D2/5-HT2 antagonist (1) ·
Dihydroindolone D2 antagonist (1) ·
Diphenylbutylpiperidine D2 antagonist (1) ·
Monoamine releasing agent (4) ·
Monoamine releasing agent; active ingredient in khat (1) ·
Multi-receptor antagonist (D2, 5-HT2A, H1, alpha) (1) ·
Norepinephrine and dopamine releasing agent (1) ·
Norepinephrine/dopamine releasing agent (1) ·
Norepinephrine/dopamine reuptake inhibitor (1) ·
Phenothiazine D2 antagonist (4) ·
Serotonin releasing agent; monoamine reuptake inhibitor (1) ·
Serotonin/norepinephrine/dopamine releasing agent (3) ·
Thioxanthene D2 antagonist (1) ·
'"`UNIQ--vote-0000032A-QINU`"' D3 (cholecalciferol) is more potent at raising serum 25(OH)D per dose; D2 remains widely prescribed in the US Rx 50,000 IU formulation'"`UNIQ--ref-0000032B-QINU`"'. (1) ·
'"`UNIQ--vote-0000042C-QINU`"' D3 is more potent than D2 at raising and sustaining serum 25(OH)D per dose, and is the more common OTC formulation; D2 remains the dominant Rx 50,000 IU formulation in the US for historical reasons. (1)
None (29) ·
Deficiency: 50,000 IU PO weekly for 8-12 weeks, then maintenance 800-2,000 IU/day; maintenance OTC dosing typically 800-2,000 IU/d (1) ·
Maintenance 800-2,000 IU PO daily; deficiency replacement 50,000 IU PO weekly for 8-12 weeks then maintenance, or equivalent daily dosing 5,000-10,000 IU/d (1)
Showing below up to 31 results in range #1 to #31.


